[{"source": "PMC", "date": "20220831", "key": "pmc.key", "infons": {}, "documents": [{"id": "9407972", "infons": {"license": "CC BY"}, "passages": [{"offset": 0, "infons": {"article-id_doi": "10.3389/fnins.2022.926830", "article-id_pmc": "9407972", "article-id_pmid": "36033622", "elocation-id": "926830", "kwd": "Alzheimer\u2019s disease genetic variant CLU genome-wide association study rs11136000 eQTL", "license": "This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.", "name_0": "surname:Ma;given-names:Jin", "name_1": "surname:Qiu;given-names:Shizheng", "section_type": "TITLE", "type": "front", "volume": "16", "year": "2022"}, "text": "Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer\u2019s disease risk", "sentences": [], "annotations": [], "relations": []}, {"offset": 99, "infons": {"section_type": "ABSTRACT", "type": "abstract"}, "text": "Clusterin (CLU) is an extracellular chaperone involved in reducing amyloid beta (A\u03b2) toxicity and aggregation. Although previous genome-wide association studies (GWAS) have reported a potential protective effect of CLU on Alzheimer\u2019s disease (AD) patients, how intron-located rs11136000 (CLU) affects AD risk by regulating CLU expression remains unknown. In this study, we integrated multiple omics data to construct the regulated pathway of rs11136000-CLU-AD. In step 1, we investigated the effects of variant rs11136000 on AD risk with different genders and diagnostic methods using GWAS summary statistics for AD from International Genomics of Alzheimer\u2019s Project (IGAP) and UK Biobank. In step 2, we assessed the regulation of rs11136000 on CLU expression in AD brain samples from Mayo clinic and controls from Genotype-Tissue Expression (GTEx). In step 3, we investigated the differential gene/protein expression of CLU in AD and controls from four large cohorts. The results showed that rs11136000 T allele reduced AD risk in either clinically diagnosed or proxy AD patients. By using expression quantitative trait loci (eQTL) analysis, rs11136000 variant downregulated CLU expression in 13 normal brain tissues, but upregulated CLU expression in cerebellum and temporal cortex of AD samples. Importantly, CLU was significantly differentially expressed in temporal cortex, dorsolateral prefrontal cortex and anterior prefrontal cortex of AD patients compared with normal controls. Together, rs11136000 may reduce AD risk by regulating CLU expression, which may provide important information about the biological mechanism of rs9848497 in AD progress.", "sentences": [], "annotations": [], "relations": []}, {"offset": 1761, "infons": {"section_type": "INTRO", "type": "title_1"}, "text": "Introduction", "sentences": [], "annotations": [], "relations": []}, {"offset": 1774, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Alzheimer\u2019s disease (AD) is a neurodegenerative disease of the central nervous system characterized by progressive cognitive dysfunction and behavioral impairment. It is estimated that at least 40 million middle-aged and elderly people worldwide suffer from AD (. Among all the AD susceptibility genes, Apolipoprotein E (APOE), which mediates the binding, internalization, and catabolism of lipoprotein particles, is considered to be the major risk factor. APOE not only co-deposits with beta-amyloid (A\u03b2) through protein-protein interaction, but also directly leads to secretion and impaired clearance of A\u03b2.", "sentences": [], "annotations": [], "relations": []}, {"offset": 2390, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Other susceptibility genes, such as CLU, also affect the occurrence and progression of AD through the accumulation and clearance of A\u03b2, nerve inflammation, and lipid metabolism. Previous genome-wide association studies (GWAS) have shown that rs11136000 (CLU) is a protective locus for AD risk, and several case-control association studies replicate this result. However, some of other studies report no statistically significant association of rs11136000 on AD or no association in non-European populations. The conflicting results of these studies made us interested in investigating the effect of rs11136000 on AD. Moreover, how rs11136000 regulates CLU expression and leads to AD needs further evaluation.", "sentences": [], "annotations": [], "relations": []}, {"offset": 3102, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "In this study, we integrated multiple omics data, including genome-wide association study (GWAS), expression quantitative trait loci (eQTLs), transcriptome and proteome data, to investigate whether rs11136000 regulates CLU expression and thereby contribute to AD. In addition, we identified the different effects of rs11136000 on AD patients of different genders.", "sentences": [], "annotations": [], "relations": []}, {"offset": 3466, "infons": {"section_type": "METHODS", "type": "title_1"}, "text": "Materials and methods", "sentences": [], "annotations": [], "relations": []}, {"offset": 3488, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Genome-wide association studies datasets", "sentences": [], "annotations": [], "relations": []}, {"offset": 3529, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Genome-wide association studies uses single nucleotide polymorphisms (SNPs) in the human genome as molecular genetic markers to analyze the correlation between genotype and phenotype, aiming to discover genetic risk variants that affect phenotype. A total of five large-scale GWAS datasets for AD were included in the statistical analysis of this study. First, we obtained two GWAS datasets for AD patients with clinical or autopsy diagnosis from International Genomics of Alzheimer\u2019s Project (IGAP), including 17,008 AD cases and 37,154 controls, and 21,982 AD cases and 41,944 controls, respectively (Table 1). In addition, we obtained three large GWAS cohorts for AD proxy from UK Biobank, including family history of maternal AD (27,696 cases and 260,980 controls), family history of patrilineal AD (14,338 cases and 245,941 controls), and family history of all AD patients. All of the participants were of European descent.", "sentences": [], "annotations": [], "relations": []}, {"offset": 4460, "infons": {"file": "T1.xml", "id": "T1", "section_type": "TABLE", "type": "table_caption"}, "text": "Data sources of GWAS.", "sentences": [], "annotations": [], "relations": []}, {"offset": 4482, "infons": {"file": "T1.xml", "id": "T1", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table frame=\"hsides\" rules=\"groups\" cellspacing=\"5\" cellpadding=\"5\"><thead><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Study</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Traits</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Diagnosis</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">Cases</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">Controls</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">Ethnicity</td></tr></thead><tbody><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">IGAP2013 <xref rid=\"B21\" ref-type=\"bibr\">Lambert et al., 2013</xref></td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">GWAS</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Clinical or autopsy</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">25,580</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">48,466</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">European</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">IGAP2019 <xref rid=\"B20\" ref-type=\"bibr\">Kunkle et al., 2019</xref></td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">GWAS</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Clinical or autopsy</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">35,274</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">59,163</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">European</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">UK Biobank (all) <xref rid=\"B24\" ref-type=\"bibr\">Marioni et al., 2018</xref></td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">GWAX</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Clinical or autopsy</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">42,034</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">272,244</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">European</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">UK Biobank (maternal) <xref rid=\"B24\" ref-type=\"bibr\">Marioni et al., 2018</xref></td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">GWAX</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Proxy</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">27,696</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">260,980</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">European</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">UK Biobank (paternal) <xref rid=\"B24\" ref-type=\"bibr\">Marioni et al., 2018</xref></td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">GWAX</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Proxy</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">14,338</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">245,941</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">European</td></tr></tbody></table>\n"}, "text": "Study\tTraits\tDiagnosis\tCases\tControls\tEthnicity\t \tIGAP2013 \tGWAS\tClinical or autopsy\t25,580\t48,466\tEuropean\t \tIGAP2019 \tGWAS\tClinical or autopsy\t35,274\t59,163\tEuropean\t \tUK Biobank (all) \tGWAX\tClinical or autopsy\t42,034\t272,244\tEuropean\t \tUK Biobank (maternal) \tGWAX\tProxy\t27,696\t260,980\tEuropean\t \tUK Biobank (paternal) \tGWAX\tProxy\t14,338\t245,941\tEuropean\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 4842, "infons": {"file": "T1.xml", "id": "T1", "section_type": "TABLE", "type": "table_footnote"}, "text": "GWAX, genome-wide association studies by proxy. GWAS, genome-wide association studies.", "sentences": [], "annotations": [], "relations": []}, {"offset": 4929, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Expression quantitative trait loci datasets", "sentences": [], "annotations": [], "relations": []}, {"offset": 4973, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Expression quantitative trait loci are genetic variants that control the expression levels of quantitative trait genes. In particular, variants located in non-coding regions may cause disease by modulating gene expression. In this study, we obtained datasets that rs11136000 regulates gene expression in AD patients and controls, respectively. The eQTL data of AD and non-AD samples were obtained from Mayo clinic and Genotype-Tissue Expression (GTEx) project, respectively (Table 2). The Mayo dataset contained gene expression data for temporal cortex (TCX) in 186 AD subjects and 170 normal subjects, and cerebellar tissue (CER) in 191 AD subjects and 181 normal subjects. In addition, eQTL data of 13 brain tissues, including amygdala, anterior cingulate cortex, caudate, cerebellar hemisphere, cerebellum, cortex, frontal cortex, hippocampus, hypothalamus, nucleus accumbens, putamen, spinal cord, and substantia nigra were obtained from GTEx (version 8) as controls. The donors in GTEx were of multiple descents including European (85.3%), African (12.3%), Asian (1.4%), etc.,.", "sentences": [], "annotations": [], "relations": []}, {"offset": 6056, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table_caption"}, "text": "The effect of genetic variant rs11136000 on CLU expression in AD and normal samples.", "sentences": [], "annotations": [], "relations": []}, {"offset": 6141, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table frame=\"hsides\" rules=\"groups\" cellspacing=\"5\" cellpadding=\"5\"><thead><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Data sources</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Brain tissue</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">No. Samples</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">Beta</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\"><italic>P</italic>-value</td></tr></thead><tbody><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">GTEx</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Amygdala (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">88</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.065</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.23</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Anterior cingulate cortex (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">109</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.10</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.027</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Caudate (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">144</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.041</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.16</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Cerebellar Hemisphere (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">125</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.0012</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.98</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Cerebellum (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">154</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.049</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.12</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Cortex (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">136</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.058</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.065</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Frontal Cortex (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">118</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.068</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.036</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Hippocampus (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">111</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.069</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.076</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Hypothalamus (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">108</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.0095</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.81</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Nucleus accumbens (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">130</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.16</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.00023</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Putamen (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">111</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.12</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.00082</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Spinal cord (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">83</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.064</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.24</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Substantia nigra (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">80</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.021</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.75</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">MAYO</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Cerebellum (AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">186</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.0635</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.23</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Cerebellum (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">170</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.0905</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.048</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Temporal cortex (AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">191</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.0588</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.031</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Temporal cortex (non-AD)</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">181</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.286</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.00029</td></tr></tbody></table>\n"}, "text": "Data sources\tBrain tissue\tNo. Samples\tBeta\tP-value\t \tGTEx\tAmygdala (non-AD)\t88\t\u22120.065\t0.23\t \t\tAnterior cingulate cortex (non-AD)\t109\t\u22120.10\t0.027\t \t\tCaudate (non-AD)\t144\t\u22120.041\t0.16\t \t\tCerebellar Hemisphere (non-AD)\t125\t\u22120.0012\t0.98\t \t\tCerebellum (non-AD)\t154\t\u22120.049\t0.12\t \t\tCortex (non-AD)\t136\t\u22120.058\t0.065\t \t\tFrontal Cortex (non-AD)\t118\t\u22120.068\t0.036\t \t\tHippocampus (non-AD)\t111\t\u22120.069\t0.076\t \t\tHypothalamus (non-AD)\t108\t\u22120.0095\t0.81\t \t\tNucleus accumbens (non-AD)\t130\t\u22120.16\t0.00023\t \t\tPutamen (non-AD)\t111\t\u22120.12\t0.00082\t \t\tSpinal cord (non-AD)\t83\t\u22120.064\t0.24\t \t\tSubstantia nigra (non-AD)\t80\t\u22120.021\t0.75\t \tMAYO\tCerebellum (AD)\t186\t0.0635\t0.23\t \t\tCerebellum (non-AD)\t170\t\u22120.0905\t0.048\t \t\tTemporal cortex (AD)\t191\t0.0588\t0.031\t \t\tTemporal cortex (non-AD)\t181\t0.286\t0.00029\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 6942, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table_footnote"}, "text": "Beta is the regression coefficient based on the effect allele. Beta > 0 and beta < 0 mean that this effect allele could increase and reduce gene expression, respectively. The statistically significant association is defined to be P < 0.05/17 = 0.00294.", "sentences": [], "annotations": [], "relations": []}, {"offset": 7195, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "RNA expression datasets", "sentences": [], "annotations": [], "relations": []}, {"offset": 7219, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "RNA-seq data for AD versus controls was generated from over 2,100 samples from post-mortem brains of more than 1,100 individuals from seven distinct brain regions from three human cohort studies, including Religious Orders Study and Memory and Aging Project (ROSMAP), Mayo RNAseq (MAYO), and Mount Sinai Brain Bank (MSBB). The seven brain regions contained dorsolateral prefrontal cortex (DLPFC), CER, TCX, frontal pole (FP), inferior frontal gyrus (IFG), parahippocampal gyrus (PHG), and superior temporal gyrus (STG).", "sentences": [], "annotations": [], "relations": []}, {"offset": 7739, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Proteomics datasets", "sentences": [], "annotations": [], "relations": []}, {"offset": 7759, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Proteomic data was generated from post-mortem brains of more than 500 individuals from four human cohort studies, including Banner Sun Health Research Institute (Banner), Baltimore Longitudinal Study on Aging (BLSA), MAYO and MSBB. Brain samples consisted of four different brain regions [DLPFC, Middle Frontal Gyrus (MFG), TCX and Anterior Prefrontal Cortex (AntPFC)]. Protein abundance was quantified using liquid-free quantification (LFQ). The proteomic data was adjusted for age, sex, and post mortem interval (PMI).", "sentences": [], "annotations": [], "relations": []}, {"offset": 8280, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "The effect of genetic variant rs11136000 on Alzheimer\u2019s disease risk", "sentences": [], "annotations": [], "relations": []}, {"offset": 8351, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "We investigated the effect of rs11136000 T allele on AD risk in GWAS summary statistics for AD of clinically diagnosed or autopsy and first-degree relative proxies, respectively. In addition, we explored the effect of rs11136000 on AD patients with different genders using GWAS by proxy (GWAX) from UK Biobank. The statistically significant association is defined to be P < 5E-08 after adjusting for multiple testing.", "sentences": [], "annotations": [], "relations": []}, {"offset": 8769, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "The effect of rs11136000 on clusterin expression in Alzheimer\u2019s disease and controls", "sentences": [], "annotations": [], "relations": []}, {"offset": 8856, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "We investigated the potential differential cis-regulated effect of rs11136000 on CLU in AD versus controls using an additive model eQTL analysis. According to the additive model, each allele has an independent effect on the trait. Here, we coded the possible genotypes of rs11136000 (TT = 2, TC = 1, CC = 0), where T is an effect allele and C is a non-effect allele. Thus, the differential regulation of CLU expression in rs11136000 T allele carriers of AD and controls can be calculated using linear regression models. The statistically significant association is defined to be P < 0.05/(number of brain tissues) = 0.05/17 = 0.00294 after multiple testing.", "sentences": [], "annotations": [], "relations": []}, {"offset": 9514, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Differential expression of clusterin between Alzheimer\u2019s disease and normal individuals", "sentences": [], "annotations": [], "relations": []}, {"offset": 9604, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "We evaluated the differential mRNA expression of CLU in seven brain regions between AD and controls from ROSMAP, MAYO and MSBB. Meanwhile, we investigated the differential protein expression of CLU in four brain regions of AD versus controls from DLPFC, MFG, TCX, and AntPFC. The differential expression was determined via ANOVA. The significance level of differential expression was defined as P < 0.05/7 = 0.00714 and P < 0.05/4 = 0.0125 after multiple testing.", "sentences": [], "annotations": [], "relations": []}, {"offset": 10068, "infons": {"section_type": "RESULTS", "type": "title_1"}, "text": "Results", "sentences": [], "annotations": [], "relations": []}, {"offset": 10076, "infons": {"section_type": "RESULTS", "type": "title_2"}, "text": "rs11136000 T allele reduced Alzheimer\u2019s disease risk", "sentences": [], "annotations": [], "relations": []}, {"offset": 10131, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "rs11136000 T allele significantly reduced AD risk in both clinically diagnosed Alzheimer\u2019s cohorts from IGAP (OR: 0.92, 95%CI: 0.91-0.94, P = 1.38E-24; OR: 0.88, 95%CI: 0.86-0.91, P = 4.90E-16) (Figure 1). In the UK Biobank cohort (using participants whose parents suffered from AD as a proxy for cases), rs11136000 T allele was suggestively protective against AD (OR: 0.95, 95%CI: 0.93-0.97, P = 1.88E-07) (Figure 1). However, rs11136000 only potentially affected female individuals with AD (OR: 0.94, 95%CI: 0.92-0.96, P = 3.96E-07).", "sentences": [], "annotations": [], "relations": []}, {"offset": 10669, "infons": {"file": "fnins-16-926830-g001.jpg", "id": "F1", "section_type": "FIG", "type": "fig_caption"}, "text": "Association between rs11136000 variant T allele and AD. IGAP, International Genomics of Alzheimer\u2019s Project. The statistically significant association is defined to be P < 5E-08.", "sentences": [], "annotations": [], "relations": []}, {"offset": 10850, "infons": {"section_type": "RESULTS", "type": "title_2"}, "text": "rs11136000 upregulated clusterin expression in Alzheimer\u2019s disease", "sentences": [], "annotations": [], "relations": []}, {"offset": 10919, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "rs11136000 downregulated CLU expression in all 13 normal brain tissues from GTEx, two of which passed multiple testing (Pnucleusaccumbens = 0.00023 and Pputamen = 0.00082) (Table 2). However, rs11136000 suggestively upregulated CLU expression in cerebellum (\u03b2 = 0.0635, P = 0.23) and temporal cortex samples of AD (\u03b2 = 0.0588, P = 0.031) (Table 2).", "sentences": [], "annotations": [], "relations": []}, {"offset": 11274, "infons": {"section_type": "RESULTS", "type": "title_2"}, "text": "Clusterin differentially expressed in Alzheimer\u2019s disease versus controls", "sentences": [], "annotations": [], "relations": []}, {"offset": 11350, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "To further determine the effect of CLU in AD patients, we investigated the differential expression of CLU between AD and controls in various brain regions at the level of gene expression and protein expression, respectively. The CLU mRNA expression in temporal cortex region of AD patients significantly differed from controls regardless of gender ( = 0.83, PTCX = 2.96E-10) (Table 3). However, CLU was only significantly differentially expressed in parahippocampal gyrus region of female AD patients compared to controls ( = 0.34, PPHG = 0.00032). Furthermore, CLU protein was detected in DLPFC and AntPFC, and was significantly differentially expressed in both two brain tissues ( = 0.29, PAntPFC = 0.00022;  = 0.23, PDLPFC = 5.09E-06) (Figure 2).", "sentences": [], "annotations": [], "relations": []}, {"offset": 12100, "infons": {"file": "T3.xml", "id": "T3", "section_type": "TABLE", "type": "table_caption"}, "text": "Differential mRNA expression of CLU in AD and normal samples.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12162, "infons": {"file": "T3.xml", "id": "T3", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" frame=\"hsides\" rules=\"groups\" cellspacing=\"5\" cellpadding=\"5\"><thead><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Phenotype</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Brain tissue</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\n<inline-formula>\n<mml:math id=\"INEQ5\" overflow=\"scroll\"><mml:mrow><mml:mtext mathvariant=\"bold\">l</mml:mtext><mml:mo>\u2062</mml:mo><mml:mi>o</mml:mi><mml:mo>\u2062</mml:mo><mml:msubsup><mml:mi>g</mml:mi><mml:mn mathvariant=\"bold\">2</mml:mn><mml:mrow><mml:mi mathvariant=\"bold\">F</mml:mi><mml:mo>\u2062</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math>\n</inline-formula>\n</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\"><italic>P</italic>-value</td></tr></thead><tbody><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">AD (all)</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Cerebellum</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.12</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.43</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Dorsolateral Prefrontal Cortex</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.016</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.78</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Frontal Pole</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.15</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.033</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Inferior Frontal Gyrus</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.13</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.13</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Parahippocampal Gyrus</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.31</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">8.17E-07</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Superior Temporal Gyrus</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.17</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.27</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Temporal Cortex</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.83</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">2.96E-10</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">AD (female)</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Cerebellum</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.20</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.29</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Dorsolateral Prefrontal Cortex</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">\u22120.013</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.87</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Frontal Pole</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.15</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.23</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Inferior Frontal Gyrus</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.19</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.14</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Parahippocampal Gyrus</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.34</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.00032</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Superior Temporal Gyrus</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.23</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.061</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Temporal Cortex</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.82</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">1.89E-06</td></tr><tr><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">AD (male)</td><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Cerebellum</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.012</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.97</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Dorsolateral Prefrontal Cortex</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.028</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.78</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Frontal Pole</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.12</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.38</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Inferior Frontal Gyrus</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.64</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.79</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Parahippocampal Gyrus</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.24</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.084</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Superior Temporal Gyrus</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.076</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.67</td></tr><tr><td rowspan=\"1\" colspan=\"1\"/><td valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Temporal Cortex</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.84</td><td valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">0.00004</td></tr></tbody></table>\n"}, "text": "Phenotype\tBrain tissue\t\tP-value\t \tAD (all)\tCerebellum\t0.12\t0.43\t \t\tDorsolateral Prefrontal Cortex\t0.016\t0.78\t \t\tFrontal Pole\t0.15\t0.033\t \t\tInferior Frontal Gyrus\t0.13\t0.13\t \t\tParahippocampal Gyrus\t0.31\t8.17E-07\t \t\tSuperior Temporal Gyrus\t0.17\t0.27\t \t\tTemporal Cortex\t0.83\t2.96E-10\t \tAD (female)\tCerebellum\t0.20\t0.29\t \t\tDorsolateral Prefrontal Cortex\t\u22120.013\t0.87\t \t\tFrontal Pole\t0.15\t0.23\t \t\tInferior Frontal Gyrus\t0.19\t0.14\t \t\tParahippocampal Gyrus\t0.34\t0.00032\t \t\tSuperior Temporal Gyrus\t0.23\t0.061\t \t\tTemporal Cortex\t0.82\t1.89E-06\t \tAD (male)\tCerebellum\t0.012\t0.97\t \t\tDorsolateral Prefrontal Cortex\t0.028\t0.78\t \t\tFrontal Pole\t0.12\t0.38\t \t\tInferior Frontal Gyrus\t0.64\t0.79\t \t\tParahippocampal Gyrus\t0.24\t0.084\t \t\tSuperior Temporal Gyrus\t0.076\t0.67\t \t\tTemporal Cortex\t0.84\t0.00004\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 12947, "infons": {"file": "T3.xml", "id": "T3", "section_type": "TABLE", "type": "table_footnote"}, "text": ": log fold change value.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12972, "infons": {"file": "fnins-16-926830-g002.jpg", "id": "F2", "section_type": "FIG", "type": "fig_caption"}, "text": "Differential protein expression of CLU between AD and normal samples. The gray boxplots represent the expression levels of CLU protein in the brain tissues of healthy participants. The orange dots represent the expression levels of CLU protein in the brain tissues of AD patients. AntPFC, anterior prefrontal cortex; DLPFC, dorsolateral prefrontal cortex.", "sentences": [], "annotations": [], "relations": []}, {"offset": 13328, "infons": {"section_type": "DISCUSS", "type": "title_1"}, "text": "Discussion", "sentences": [], "annotations": [], "relations": []}, {"offset": 13339, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "Large-scale GWAS in recent years have identified substantial genetic variants and genes associated with AD risk. Susceptibility loci including APOE have been confirmed by numerous studies. CLU, also known as apolipoprotein J (APOJ) protein, is identified as the third-highest risk gene for late-onset AD (LOAD), contributing approximately 9% of AD risk. Previous studies have shown that elevated CLU levels have been detected in the brain and plasma of AD individuals and are involved in neuroinflammation, lipid metabolism, and A\u03b2 clearance in AD patients. However, some studies have also reported that CLU incorporation into amyloid aggregates is more harmful than A\u03b242 aggregates alone. The ambiguous and complex role of CLU in AD prevents it from becoming a therapeutic target for AD.", "sentences": [], "annotations": [], "relations": []}, {"offset": 14134, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "In this study, we integrated GWAS, eQTL, gene expression and protein expression data to investigate whether rs11136000 (CLU) affects AD risk by regulating CLU expression. We successfully explained the pathway of rs11136000-CLU-AD. The results showed that rs11136000 significantly reduced AD risk in both clinically diagnosed AD and AD proxy. The effects of rs11136000 on AD risk with different genders and different diagnostic modalities were slightly different. In addition, previous meta-analyses and systematic reviews suggested that the heterogeneity of rs11136000 on AD risk was also reflected by race. Both and believed that rs11136000 only reduced the risk of AD in the European population, while the association was weak in the East Asian population. Subsequent eQTL analysis revealed heterogeneity of rs11136000 expression in various brain tissues. Significant difference of the regulation of rs11136000 on CLU expression was only showed in temporal cortex region between AD patients versus controls. Interestingly, CLU-immunopositive A\u03b2 deposits were found in the temporal cortex of AD patients, and 29% of A\u03b2 in brain tissue was associated with CLU protein.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15309, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "The study has some advantages. The multiple omics data used in this study were all from European populations, avoiding the bias associated with population stratification. Multiple omics data constructed a complete pathway that genetic variants regulate gene expression and then affect disease phenotype, which better explains the role of rs11136000 in the brain of AD patients than previous studies. However, this study also has certain limitations. It is difficult for us to obtain gender- and ethnic-specific multi-omics data, which limits the further disclosure of the specific regulatory role of rs11136000 on AD patients in different populations.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15961, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "In conclusion, this study highlights the potential role of the variant rs11136000 on AD risk by regulating CLU expression. These findings reveal the importance of a better understanding of CLU function and dysfunction in the context of normal and AD individuals.", "sentences": [], "annotations": [], "relations": []}, {"offset": 16224, "infons": {"section_type": "SUPPL", "type": "title_1"}, "text": "Data availability statement", "sentences": [], "annotations": [], "relations": []}, {"offset": 16252, "infons": {"section_type": "SUPPL", "type": "paragraph"}, "text": "The original contributions presented in this study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.", "sentences": [], "annotations": [], "relations": []}, {"offset": 16418, "infons": {"section_type": "AUTH_CONT", "type": "title_1"}, "text": "Author contributions", "sentences": [], "annotations": [], "relations": []}, {"offset": 16439, "infons": {"section_type": "AUTH_CONT", "type": "paragraph"}, "text": "SQ analyzed the data and drafted the manuscript. JM designed the study, revised the manuscript, and supervised this work. Both authors reviewed and approved the final version.", "sentences": [], "annotations": [], "relations": []}, {"offset": 16615, "infons": {"section_type": "COMP_INT", "type": "title_1"}, "text": "Conflict of interest", "sentences": [], "annotations": [], "relations": []}, {"offset": 16636, "infons": {"section_type": "COMP_INT", "type": "paragraph"}, "text": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.", "sentences": [], "annotations": [], "relations": []}, {"offset": 16809, "infons": {"section_type": "COMP_INT", "type": "title_1"}, "text": "Publisher\u2019s note", "sentences": [], "annotations": [], "relations": []}, {"offset": 16828, "infons": {"section_type": "COMP_INT", "type": "paragraph"}, "text": "All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17175, "infons": {"section_type": "REF", "type": "title"}, "text": "References", "sentences": [], "annotations": [], "relations": []}, {"offset": 17186, "infons": {"issue": "5086250", "name_0": "surname:Al Mamun;given-names:A.", "name_1": "surname:Uddin;given-names:M. S.", "name_2": "surname:Bin Bashar;given-names:M. F.", "name_3": "surname:Zaman;given-names:S.", "name_4": "surname:Begum;given-names:Y.", "name_5": "surname:Bulbul;given-names:I. J.", "pub-id_doi": "10.1155/2020/5086250", "pub-id_pmid": "32509144", "section_type": "REF", "source": "Oxid. Med. Cell. Longev.", "type": "ref", "volume": "2020", "year": "2020"}, "text": "Molecular insight into the therapeutic promise of targeting APOE4 for Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17279, "infons": {"fpage": "221", "lpage": "228", "name_0": "surname:Allen;given-names:M.", "name_1": "surname:Zou;given-names:F.", "name_2": "surname:Chai;given-names:H. S.", "name_3": "surname:Younkin;given-names:C. S.", "name_4": "surname:Crook;given-names:J.", "name_5": "surname:Pankratz;given-names:V. S.", "pub-id_doi": "10.1212/WNL.0b013e3182605801", "pub-id_pmid": "22722634", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "79", "year": "2012"}, "text": "Novel late-onset Alzheimer disease loci variants associate with brain gene expression.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17366, "infons": {"fpage": "327", "lpage": "406", "pub-id_doi": "10.1002/alz.12328", "pub-id_pmid": "33756057", "section_type": "REF", "source": "Alzheimers Dement", "type": "ref", "volume": "17", "year": "2021"}, "text": "2021 Alzheimer\u2019s disease facts and figures", "sentences": [], "annotations": [], "relations": []}, {"offset": 17411, "infons": {"fpage": "411", "lpage": "422", "name_0": "surname:Balcar;given-names:V. J.", "name_1": "surname:Zeman;given-names:T.", "name_2": "surname:Janout;given-names:V.", "name_3": "surname:Janoutova;given-names:J.", "name_4": "surname:Lochman;given-names:J.", "name_5": "surname:Sery;given-names:O.", "pub-id_doi": "10.1007/s11064-020-03176-y", "pub-id_pmid": "33206315", "section_type": "REF", "source": "Neurochem. Res.", "type": "ref", "volume": "46", "year": "2021"}, "text": "Single nucleotide polymorphism rs11136000 of CLU gene (Clusterin, ApoJ) and the risk of late-onset Alzheimer\u2019s disease in a central European population.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17566, "infons": {"fpage": "820", "lpage": "838", "name_0": "surname:Belloy;given-names:M. E.", "name_1": "surname:Napolioni;given-names:V.", "name_2": "surname:Greicius;given-names:M. D.", "pub-id_doi": "10.1016/j.neuron.2019.01.056", "pub-id_pmid": "30844401", "section_type": "REF", "source": "Neuron", "type": "ref", "volume": "101", "year": "2019"}, "text": "A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17658, "infons": {"fpage": "628", "lpage": "645", "name_0": "surname:Bennett;given-names:D. A.", "name_1": "surname:Schneider;given-names:J. A.", "name_2": "surname:Arvanitakis;given-names:Z.", "name_3": "surname:Wilson;given-names:R. S.", "pub-id_doi": "10.2174/156720512801322573", "pub-id_pmid": "22471860", "section_type": "REF", "source": "Curr. Alzheimer Res.", "type": "ref", "volume": "9", "year": "2012a"}, "text": "Overview and findings from the religious orders study.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17713, "infons": {"fpage": "646", "lpage": "663", "name_0": "surname:Bennett;given-names:D. A.", "name_1": "surname:Schneider;given-names:J. A.", "name_2": "surname:Buchman;given-names:A. S.", "name_3": "surname:Barnes;given-names:L. L.", "name_4": "surname:Boyle;given-names:P. A.", "name_5": "surname:Wilson;given-names:R. S.", "pub-id_doi": "10.2174/156720512801322663", "pub-id_pmid": "22471867", "section_type": "REF", "source": "Curr. Alzheimer Res.", "type": "ref", "volume": "9", "year": "2012b"}, "text": "Overview and findings from the rush memory and aging project.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17775, "infons": {"fpage": "17", "lpage": "23", "name_0": "surname:Bertram;given-names:L.", "name_1": "surname:Mcqueen;given-names:M. B.", "name_2": "surname:Mullin;given-names:K.", "name_3": "surname:Blacker;given-names:D.", "name_4": "surname:Tanzi;given-names:R. E.", "pub-id_doi": "10.1038/ng1934", "pub-id_pmid": "17192785", "section_type": "REF", "source": "Nat. Genet.", "type": "ref", "volume": "39", "year": "2007"}, "text": "Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17872, "infons": {"fpage": "333", "lpage": "344", "name_0": "surname:Bu;given-names:G. J.", "pub-id_doi": "10.1038/nrn2620", "pub-id_pmid": "19339974", "section_type": "REF", "source": "Nat Rev Neurosci.", "type": "ref", "volume": "10", "year": "2009"}, "text": "Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17969, "infons": {"fpage": "961", "lpage": "964", "name_0": "surname:Carrasquillo;given-names:M. M.", "name_1": "surname:Belbin;given-names:O.", "name_2": "surname:Hunter;given-names:T. A.", "name_3": "surname:Ma;given-names:L.", "name_4": "surname:Bisceglio;given-names:G. D.", "name_5": "surname:Zou;given-names:F.", "pub-id_doi": "10.1001/archneurol.2010.147", "pub-id_pmid": "20554627", "section_type": "REF", "source": "Arch Neurol.", "type": "ref", "volume": "67", "year": "2010"}, "text": "Replication of CLU, CR1, and PICALM associations with alzheimer disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18042, "infons": {"issue": "164", "name_0": "surname:Foster;given-names:E. M.", "name_1": "surname:Dangla-Valls;given-names:A.", "name_2": "surname:Lovestone;given-names:S.", "name_3": "surname:Ribe;given-names:E. M.", "name_4": "surname:Buckley;given-names:N. J.", "pub-id_doi": "10.3389/fnins.2019.00164", "pub-id_pmid": "30872998", "section_type": "REF", "source": "Front Neurosci.", "type": "ref", "volume": "13", "year": "2019"}, "text": "Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18136, "infons": {"fpage": "204", "lpage": "213", "pub-id_pmid": "29022597", "section_type": "REF", "source": "Nature", "type": "ref", "volume": "550", "year": "2017"}, "text": "Genetic effects on gene expression across human tissues.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18193, "infons": {"issue": "11062", "name_0": "surname:Han;given-names:Z. J.", "name_1": "surname:Qu;given-names:J. J.", "name_2": "surname:Zhao;given-names:J. H.", "name_3": "surname:Zou;given-names:X.", "pub-id_doi": "10.1038/s41598-018-29450-2", "pub-id_pmid": "30038359", "section_type": "REF", "source": "Sci. Rep.", "type": "ref", "volume": "8", "year": "2018"}, "text": "Analyzing 74,248 samples confirms the association between CLU rs11136000 polymorphism and Alzheimer\u2019s disease in caucasian but not Chinese population.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18346, "infons": {"fpage": "1088", "lpage": "1093", "name_0": "surname:Harold;given-names:D.", "name_1": "surname:Abraham;given-names:R.", "name_2": "surname:Hollingworth;given-names:P.", "name_3": "surname:Sims;given-names:R.", "name_4": "surname:Gerrish;given-names:A.", "name_5": "surname:Hamshere;given-names:M. L.", "pub-id_pmid": "19734902", "section_type": "REF", "source": "Nat. Genet.", "type": "ref", "volume": "41", "year": "2009"}, "text": "Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18453, "infons": {"issue": "11", "name_0": "surname:Hu;given-names:Y.", "name_1": "surname:Sun;given-names:J. Y.", "name_2": "surname:Zhang;given-names:Y.", "name_3": "surname:Zhang;given-names:H.", "name_4": "surname:Gao;given-names:S.", "name_5": "surname:Wang;given-names:T.", "pub-id_doi": "10.1186/s12916-020-01883-5", "pub-id_pmid": "33461566", "section_type": "REF", "source": "BMC Med.", "type": "ref", "volume": "19", "year": "2021b"}, "text": "rs1990622 variant associates with Alzheimer\u2019s disease and regulates TMEM106B expression in human brain tissues.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18567, "infons": {"issue": "7036592", "name_0": "surname:Hu;given-names:Y.", "name_1": "surname:Qiu;given-names:S.", "name_2": "surname:Cheng;given-names:L.", "pub-id_doi": "10.1155/2021/7036592", "pub-id_pmid": "34447459", "section_type": "REF", "source": "Comput. Math. Methods Med.", "type": "ref", "volume": "2021", "year": "2021a"}, "text": "Integration of multiple-omics data to analyze the population-specific differences for coronary artery disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18678, "infons": {"issue": "e95", "name_0": "surname:Hu;given-names:Y.", "name_1": "surname:Zhang;given-names:H.", "name_2": "surname:Liu;given-names:B.", "name_3": "surname:Gao;given-names:S.", "name_4": "surname:Wang;given-names:T.", "name_5": "surname:Han;given-names:Z.", "section_type": "REF", "source": "Brain", "type": "ref", "volume": "143", "year": "2020"}, "text": "rs34331204 regulates TSPAN13 expression and contributes to Alzheimer\u2019s disease with sex differences.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18781, "infons": {"fpage": "824", "lpage": "836", "name_0": "surname:Huynh;given-names:T. V.", "name_1": "surname:Davis;given-names:A. A.", "name_2": "surname:Ulrich;given-names:J. D.", "name_3": "surname:Holtzman;given-names:D. M.", "pub-id_pmid": "28246336", "section_type": "REF", "source": "J. Lipid Res.", "type": "ref", "volume": "58", "year": "2017"}, "text": "Apolipoprotein E and Alzheimer\u2019s disease: the influence of apolipoprotein E on amyloid-beta and other amyloidogenic proteins.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18909, "infons": {"fpage": "404", "lpage": "413", "name_0": "surname:Jansen;given-names:I. E.", "name_1": "surname:Savage;given-names:J. E.", "name_2": "surname:Watanabe;given-names:K.", "name_3": "surname:Bryois;given-names:J.", "name_4": "surname:Williams;given-names:D. M.", "name_5": "surname:Steinberg;given-names:S.", "pub-id_pmid": "30617256", "section_type": "REF", "source": "Nat. Genet.", "type": "ref", "volume": "51", "year": "2019"}, "text": "Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19019, "infons": {"fpage": "414", "lpage": "430", "name_0": "surname:Kunkle;given-names:B. W.", "name_1": "surname:Grenier-Boley;given-names:B.", "name_2": "surname:Sims;given-names:R.", "name_3": "surname:Bis;given-names:J. C.", "name_4": "surname:Damotte;given-names:V.", "name_5": "surname:Naj;given-names:A. C.", "pub-id_pmid": "30820047", "section_type": "REF", "source": "Nat. Genet.", "type": "ref", "volume": "51", "year": "2019"}, "text": "Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19159, "infons": {"fpage": "1452", "lpage": "1458", "name_0": "surname:Lambert;given-names:J. C.", "name_1": "surname:Ibrahim-Verbaas;given-names:C. A.", "name_2": "surname:Harold;given-names:D.", "name_3": "surname:Naj;given-names:A. C.", "name_4": "surname:Sims;given-names:R.", "name_5": "surname:Bellenguez;given-names:C.", "pub-id_doi": "10.1038/ng.2802", "pub-id_pmid": "24162737", "section_type": "REF", "source": "Nat. Genet.", "type": "ref", "volume": "45", "year": "2013"}, "text": "Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19260, "infons": {"fpage": "1144", "lpage": "1152", "name_0": "surname:Lancaster;given-names:T. M.", "name_1": "surname:Brindley;given-names:L. M.", "name_2": "surname:Tansey;given-names:K. E.", "name_3": "surname:Sims;given-names:R. C.", "name_4": "surname:Mantripragada;given-names:K.", "name_5": "surname:Owen;given-names:M. J.", "pub-id_doi": "10.1016/j.jalz.2014.10.012", "pub-id_pmid": "25496871", "section_type": "REF", "source": "Alzheimers Dement.", "type": "ref", "volume": "11", "year": "2015"}, "text": "Alzheimer\u2019s disease risk variant in CLU is associated with neural inefficiency in healthy individuals.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19365, "infons": {"fpage": "511", "lpage": "521", "name_0": "surname:Lidstrom;given-names:A. M.", "name_1": "surname:Bogdanovic;given-names:N.", "name_2": "surname:Hesse;given-names:C.", "name_3": "surname:Volkman;given-names:I.", "name_4": "surname:Davidsson;given-names:P.", "name_5": "surname:Blennow;given-names:K.", "pub-id_pmid": "9878186", "section_type": "REF", "source": "Exp. Neurol.", "type": "ref", "volume": "154", "year": "1998"}, "text": "Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19486, "infons": {"issue": "99", "name_0": "surname:Marioni;given-names:R. E.", "name_1": "surname:Harris;given-names:S. E.", "name_2": "surname:Zhang;given-names:Q.", "name_3": "surname:Mcrae;given-names:A. F.", "name_4": "surname:Hagenaars;given-names:S. P.", "name_5": "surname:Hill;given-names:W. D.", "section_type": "REF", "source": "Transl. Psychiatry", "type": "ref", "volume": "8", "year": "2018"}, "text": "GWAS on family history of Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19535, "infons": {"fpage": "231", "lpage": "241", "name_0": "surname:Martin-Rehrmann;given-names:M. D.", "name_1": "surname:Hoe;given-names:H. S.", "name_2": "surname:Capuani;given-names:E. M.", "name_3": "surname:Rebeck;given-names:G. W.", "pub-id_doi": "10.1007/BF03036452", "pub-id_pmid": "15897157", "section_type": "REF", "source": "Neurotox. Res.", "type": "ref", "volume": "7", "year": "2005"}, "text": "Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer\u2019s disease brain.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19654, "infons": {"fpage": "163", "lpage": "166", "name_0": "surname:Namba;given-names:Y.", "name_1": "surname:Tomonaga;given-names:M.", "name_2": "surname:Kawasaki;given-names:H.", "name_3": "surname:Otomo;given-names:E.", "name_4": "surname:Ikeda;given-names:K.", "pub-id_pmid": "2029618", "section_type": "REF", "source": "Brain Res.", "type": "ref", "volume": "541", "year": "1991"}, "text": "Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19824, "infons": {"fpage": "1418", "lpage": "1426", "name_0": "surname:Ng;given-names:B.", "name_1": "surname:White;given-names:C. C.", "name_2": "surname:Klein;given-names:H. U.", "name_3": "surname:Sieberts;given-names:S. K.", "name_4": "surname:Mccabe;given-names:C.", "name_5": "surname:Patrick;given-names:E.", "pub-id_doi": "10.1038/nn.4632", "pub-id_pmid": "28869584", "section_type": "REF", "source": "Nat. Neurosci.", "type": "ref", "volume": "20", "year": "2017"}, "text": "An xQTL map integrates the genetic architecture of the human brain\u2019s transcriptome and epigenome.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19924, "infons": {"fpage": "300", "lpage": "310", "name_0": "surname:Pimenova;given-names:A. A.", "name_1": "surname:Raj;given-names:T.", "name_2": "surname:Goate;given-names:A. M.", "pub-id_pmid": "28666525", "section_type": "REF", "source": "Biol. Psychiatry", "type": "ref", "volume": "83", "year": "2018"}, "text": "Untangling genetic risk for Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19975, "infons": {"comment": "[Epub ahead of print]", "name_0": "surname:Qiu;given-names:S.", "name_1": "surname:Hu;given-names:Y.", "name_2": "surname:Cheng;given-names:L.", "pub-id_doi": "10.1002/alz.12548", "pub-id_pmid": "34978146", "section_type": "REF", "source": "Alzheimers Dement.", "type": "ref", "year": "2022"}, "text": "BIN1 rs744373 located in enhancers of brain tissues upregulates BIN1 mRNA expression, thereby leading to Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20103, "infons": {"fpage": "505", "lpage": "517", "name_0": "surname:Scheltens;given-names:P.", "name_1": "surname:Blennow;given-names:K.", "name_2": "surname:Breteler;given-names:M. M.", "name_3": "surname:De Strooper;given-names:B.", "name_4": "surname:Frisoni;given-names:G. B.", "name_5": "surname:Salloway;given-names:S.", "pub-id_pmid": "26921134", "section_type": "REF", "source": "Lancet", "type": "ref", "volume": "388", "year": "2016"}, "text": "Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20126, "infons": {"fpage": "392", "lpage": "402", "name_0": "surname:Schwartzentruber;given-names:J.", "name_1": "surname:Cooper;given-names:S.", "name_2": "surname:Liu;given-names:J. Z.", "name_3": "surname:Barrio-Hernandez;given-names:I.", "name_4": "surname:Bello;given-names:E.", "name_5": "surname:Kumasaka;given-names:N.", "pub-id_pmid": "33589840", "section_type": "REF", "source": "Nat. Genet.", "type": "ref", "volume": "53", "year": "2021"}, "text": "Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20245, "infons": {"fpage": "4333", "lpage": "4344", "name_0": "surname:Seripa;given-names:D.", "name_1": "surname:Panza;given-names:F.", "name_2": "surname:Paroni;given-names:G.", "name_3": "surname:D\u2019onofrio;given-names:G.", "name_4": "surname:Bisceglia;given-names:P.", "name_5": "surname:Gravina;given-names:C.", "pub-id_doi": "10.1007/s12035-017-0547-x", "pub-id_pmid": "28631188", "section_type": "REF", "source": "Mol. Neurobiol.", "type": "ref", "volume": "55", "year": "2018"}, "text": "Role of CLU, PICALM, and TNK1 genotypes in aging with and without Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20334, "infons": {"fpage": "1832", "lpage": "1840", "name_0": "surname:Seshadri;given-names:S.", "name_1": "surname:Fitzpatrick;given-names:A. L.", "name_2": "surname:Ikram;given-names:M. A.", "name_3": "surname:Destefano;given-names:A. L.", "name_4": "surname:Gudnason;given-names:V.", "name_5": "surname:Boada;given-names:M.", "pub-id_doi": "10.1001/jama.2010.574", "pub-id_pmid": "20460622", "section_type": "REF", "source": "JAMA", "type": "ref", "volume": "303", "year": "2010"}, "text": "Genome-wide analysis of genetic loci associated with Alzheimer disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20406, "infons": {"fpage": "467", "lpage": "484", "name_0": "surname:Tam;given-names:V.", "name_1": "surname:Patel;given-names:N.", "name_2": "surname:Turcotte;given-names:M.", "name_3": "surname:Bosse;given-names:Y.", "name_4": "surname:Pare;given-names:G.", "name_5": "surname:Meyre;given-names:D.", "pub-id_doi": "10.1038/s41576-019-0127-1", "pub-id_pmid": "31068683", "section_type": "REF", "source": "Nat. Rev. Genet.", "type": "ref", "volume": "20", "year": "2019"}, "text": "Benefits and limitations of genome-wide association studies.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20467, "infons": {"fpage": "739", "lpage": "748", "name_0": "surname:Thambisetty;given-names:M.", "name_1": "surname:Simmons;given-names:A.", "name_2": "surname:Velayudhan;given-names:L.", "name_3": "surname:Hye;given-names:A.", "name_4": "surname:Campbell;given-names:J.", "name_5": "surname:Zhang;given-names:Y.", "pub-id_doi": "10.1001/archgenpsychiatry.2010.78", "pub-id_pmid": "20603455", "section_type": "REF", "source": "Arch Gen Psychiatry.", "type": "ref", "volume": "67", "year": "2010"}, "text": "Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20577, "infons": {"fpage": "2108", "lpage": "2119", "name_0": "surname:Uddin;given-names:M. S.", "name_1": "surname:Kabir;given-names:M. T.", "name_2": "surname:Begum;given-names:M. M.", "name_3": "surname:Islam;given-names:M. S.", "name_4": "surname:Behl;given-names:T.", "name_5": "surname:Ashraf;given-names:G. M.", "pub-id_doi": "10.1007/s12640-020-00271-4", "pub-id_pmid": "32820456", "section_type": "REF", "source": "Neurotox. Res.", "type": "ref", "volume": "39", "year": "2020a"}, "text": "Exploring the role of CLU in the pathogenesis of Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20649, "infons": {"issue": "5858", "name_0": "surname:Uddin;given-names:M. S.", "name_1": "surname:Kabir;given-names:M. T.", "name_2": "surname:Rahman;given-names:M. S.", "name_3": "surname:Behl;given-names:T.", "name_4": "surname:Jeandet;given-names:P.", "name_5": "surname:Ashraf;given-names:G. M.", "pub-id_doi": "10.3390/ijms21165858", "pub-id_pmid": "32824102", "section_type": "REF", "source": "Int. J. Mol. Sci.", "type": "ref", "volume": "21", "year": "2020b"}, "text": "Revisiting the amyloid cascade hypothesis: from anti-a beta therapeutics to auspicious new ways for Alzheimer\u2019s disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20772, "infons": {"fpage": "421", "lpage": "430", "name_0": "surname:Van Cauwenberghe;given-names:C.", "name_1": "surname:Van Broeckhoven;given-names:C.", "name_2": "surname:Sleegers;given-names:K.", "pub-id_doi": "10.1038/gim.2015.117", "pub-id_pmid": "26312828", "section_type": "REF", "source": "Genet. Med.", "type": "ref", "volume": "18", "year": "2016"}, "text": "The genetic landscape of Alzheimer disease: clinical implications and perspectives.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20856, "infons": {"fpage": "679", "lpage": "689", "name_0": "surname:Zhu;given-names:R. X.", "name_1": "surname:Liu;given-names:X.", "name_2": "surname:He;given-names:Z. Y.", "pub-id_doi": "10.1007/s10072-018-3259-8", "pub-id_pmid": "29396813", "section_type": "REF", "source": "Neurol. Sci.", "type": "ref", "volume": "39", "year": "2018"}, "text": "Association between CLU gene rs11136000 polymorphism and Alzheimer\u2019s disease: an updated meta-analysis.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20962, "infons": {"issue": "e1002707", "name_0": "surname:Zou;given-names:F. G.", "name_1": "surname:Chai;given-names:H. S.", "name_2": "surname:Younkin;given-names:C. S.", "name_3": "surname:Allen;given-names:M.", "name_4": "surname:Crook;given-names:J.", "name_5": "surname:Pankratz;given-names:V. S.", "pub-id_doi": "10.1371/journal.pgen.1002707", "pub-id_pmid": "22685416", "section_type": "REF", "source": "PLoS Genet.", "type": "ref", "volume": "8", "year": "2012"}, "text": "Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.", "sentences": [], "annotations": [], "relations": []}], "annotations": [], "relations": []}]}]